Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Burden of Ischemic Heart Disease and the Epidemiologic Transition in the Eastern Mediterranean Region: 1990–2019 Publisher Pubmed



Sadeghi M1 ; Jamalian M2 ; Mehrabanizeinabad K3 ; Turkadawi K4 ; Kopec J5, 6 ; Almahmeed W7 ; Abdul Rahim HF8 ; Farhan HA9 ; Anwar W10 ; Manla Y7, 11 ; Fadhil I12 ; Lui M5 ; Roohafza H13 ; Islam SMS14 Show All Authors
Authors
  1. Sadeghi M1
  2. Jamalian M2
  3. Mehrabanizeinabad K3
  4. Turkadawi K4
  5. Kopec J5, 6
  6. Almahmeed W7
  7. Abdul Rahim HF8
  8. Farhan HA9
  9. Anwar W10
  10. Manla Y7, 11
  11. Fadhil I12
  12. Lui M5
  13. Roohafza H13
  14. Islam SMS14
  15. Sulaiman K15
  16. Bazargani N16
  17. Saade G17
  18. Hassen N5, 6
  19. Alandejani A5
  20. Abdin A18
  21. Bokhari S19
  22. Roth GA20, 21
  23. Johnson C20
  24. Stark B20
  25. Sarrafzadegan N5, 22
  26. Mokdad AH20, 21
Show Affiliations
Authors Affiliations
  1. 1. Cardiovascular Research Institute, Cardiac Rehabilitation Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Cardiovascular Research Institute, Hypertension Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Cardiovascular Research Institute, Pediatric Cardiovascular Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Department of Public Health, QU-Health, Qatar University, Doha, Qatar
  5. 5. School of Population & Public Health, University of British Columbia, Vancouver, Canada
  6. 6. Arthritis Research Canada, Vancouver, Canada
  7. 7. Heart and Vascular Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates
  8. 8. Department of Public Health, College of Health Sciences, QU Health, Qatar University, Doha, Qatar
  9. 9. Scientific Council of Cardiology, Iraqi Board for Medical Specializations, Baghdad Heart Center, Baghdad, Iraq
  10. 10. Faculty of Medicine, Community Medicine Department, Ain Shams University, Egypt and Armed Forces College of Medicine (AFCM), Cairo, Egypt
  11. 11. Faculty of Medicine, Aleppo University, Aleppo, Syrian Arab Republic
  12. 12. Eastern Mediterranean NCD Alliance, Alsafat, Kuwait
  13. 13. Cardiovascular Research Institute, Interventional Cardiology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  14. 14. Institute for Physical Activity and Nutrition, Deakin University, Melbourne, Australia
  15. 15. National Heart Center, Royal Hospital, Muscat, Oman
  16. 16. Department of Cardiology, Dubai Hospital, Dubai, United Arab Emirates
  17. 17. Department of Cardiology, Bellevue Medical Center, Beirut, Lebanon
  18. 18. Syrian Cardiovascular Association, Damascus, Syrian Arab Republic
  19. 19. Department of Medicine, Aga Khan University Hospital, Karachi, Pakistan
  20. 20. Institute for Health Metrics and Evaluation, University of Washington, Seattle, United States
  21. 21. Department of Health Metrics Sciences, University of Washington, Seattle, United States
  22. 22. Cardiovascular Research Institute, Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Source: PLoS ONE Published:2023


Abstract

It has been estimated that in the next decade, IHD prevalence, DALYs and deaths will increase more significantly in EMR than in any other region of the world. This study aims to provide a comprehensive description of the trends in the burden of ischemic heart disease (IHD) across the countries of the Eastern Mediterranean Region (EMR) from 1990 to 2019. Data on IHD prevalence, disability-adjusted life years (DALYs), mortality, DALYs attributable to risk factors, healthcare access and quality index (HAQ), and universal health coverage (UHC) were extracted from the Global Burden of Disease (GBD) database for EMR countries. The data were stratified based on the social demographic index (SDI). Information on cardiac rehabilitation was obtained from publications by the International Council of Cardiovascular Prevention and Rehabilitation (ICCPR), and additional country-specific data were obtained through advanced search methods. Age standardization was performed using the direct method, applying the estimated age structure of the global population from 2019. Uncertainty intervals were calculated through 1000 iterations, and the 2.5th and 97.5th percentiles were derived from these calculations. The age-standardized prevalence of IHD in the EMR increased from 5.0% to 5.5% between 1990 and 2019, while it decreased at the global level. In the EMR, the age-standardized rates of IHD mortality and DALYs decreased by 11.4% and 15.4%, respectively, during the study period, although both rates remained higher than the global rates. The burden of IHD was found to be higher in males compared to females. Bahrain exhibited the highest decrease in age-standardized prevalence (-3.7%), mortality (-65.0%), and DALYs (-69.1%) rates among the EMR countries. Conversely, Oman experienced the highest increase in prevalence (14.5%), while Pakistan had the greatest increase in mortality (30.0%) and DALYs (32.0%) rates. The top three risk factors contributing to IHD DALYs in the EMR in 2019 were high systolic blood pressure, high low-density lipoprotein cholesterol, and particulate matter pollution. The trend analysis over the 29-year period (1990–2019) revealed that high fasting plasma glucose (64.0%) and high body mass index (23.4%) exhibited increasing trends as attributed risk factors for IHD DALYs in the EMR. Our findings indicate an increasing trend in the prevalence of IHD and a decrease in mortality and DALYs in the EMR. These results emphasize the need for well-planned prevention and treatment strategies to address the risk factors associated with IHD. It is crucial for the countries in this region to prioritize the development and implementation of programs focused on health promotion, education, prevention, and medical care. Copyright: © 2023 Sadeghi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Other Related Docs
18. Cardiac Rehabilitation Costs, International Journal of Cardiology (2017)
48. The Isfahan Cohort Study: Rationale, Methods and Main Findings, Journal of Human Hypertension (2011)